TrialJournal of Crohn's & colitis2019

Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis.

William J Sandborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.